ASTEC:NSE-Astec LifeSciences Limited (INR)

COMMON STOCK | Agricultural Inputs | NSE

Last Closing Price

INR 1,831.65

Change

0.00 (0.00)%

Market Cap

INR 35.45B

Volume

0.01M

Avg Analyst Target

N/A

Avg User Target

INR
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


Astec LifeSciences Limited (ASTEC) Stock Analysis:
Based on the Astec LifeSciences Limited stock forecasts from 0 analysts, the average analyst target price for Astec LifeSciences Limited is not available over the next 12 months. Astec LifeSciences Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Astec LifeSciences Limited is Neutral, which is based on 7 positive signals and 6 negative signals. At the last closing, Astec LifeSciences Limited’s stock price was INR 1,831.65. Astec LifeSciences Limited’s stock price has changed by +9.94% over the past week, +0.94% over the past month and +43.66% over the last year.

No recent analyst target price found for Astec LifeSciences Limited
No recent average analyst rating found for Astec LifeSciences Limited

About

Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. The company manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazo ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-05-21 )

Largest Industry Peers for Agricultural Inputs

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
UPL:NSE UPL Limited

N/A

INR612.16B 17.74 8.65
PIIND:NSE PI Industries Limited

N/A

INR401.61B 47.61 30.27
COROMANDEL:NSE Coromandel International Limit..

N/A

INR271.37B 17.78 11.27
SUMICHEM:NSE Sumitomo Chemical India Limite..

N/A

INR218.05B 54.07 33.86
BAYERCROP:NSE Bayer Cropscience Limited

N/A

INR212.53B 38.25 24.80
CHAMBLFERT:NSE Chambal Fertilizers & Chemical..

N/A

INR164.82B 9.31 6.94
FACT:NSE Fertilizers and Chemicals Trav..

N/A

INR80.66B 22.83 10.01
SHARDACROP:NSE Sharda Cropchem Limited

N/A

INR64.37B 18.43 8.40
GSFC:NSE Gujarat State Fertilizers & Ch..

N/A

INR62.96B 8.26 4.01
RCF:NSE Rashtriya Chemicals and Fertil..

N/A

INR54.53B 8.77 4.37

ETFs Containing ASTEC

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Agricultural Inputs)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 27.88% 69% D+ 89% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.88% 69% D+ 89% B+
Trailing 12 Months  
Capital Gain 43.66% 71% C- 69% D+
Dividend Return 0.12% 12% F 3% F
Total Return 43.78% 71% C- 68% D+
Trailing 5 Years  
Capital Gain 222.70% 91% A- 88% B+
Dividend Return 1.08% 18% F 14% F
Total Return 223.78% 91% A- 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 43.31% 86% B 79% C+
Dividend Return 0.18% 19% F 15% F
Total Return 43.49% 86% B 79% C+
Risk Return Profile  
Volatility (Standard Deviation) 75.43% 25% F 33% F
Risk Adjusted Return 57.66% 75% C 80% B-
Market Capitalization 35.45B 66% D 69% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Agricultural Inputs)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 39.46 18% F 26% F
Price/Book Ratio 8.86 15% F 11% F
Price / Cash Flow Ratio 150.20 9% F 4% F
EV/EBITDA 23.00 21% F 27% F
Management Effectiveness  
Return on Equity 25.46% 76% C 87% B+
Return on Invested Capital 20.43% 79% C+ 89% B+
Return on Assets 9.51% 71% C- 81% B-
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield 0.08% 7% F 2% F
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.64 63% D 67% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.